NCT00349986View on ClinicalTrials.gov

LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

PHASE4TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insuline glargine

Trial Locations (1)

Unknown

Sanofi-Aventis, Budapest

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY